|
2014 Journal Article Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modellingStørset, Elisabet, Holford, Nick, Hennig, Stefanie, Bergmann, Troels K., Bremer, Stein, Bergan, Sara, Åsberg, Anders, Midtvedt, Karsten and Staatz, Christine E. (2014). Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling. British Journal of Clinical Pharmacology, 78 (3), 509-523. doi: 10.1111/bcp.12361 |
|
2014 Conference Publication Evaluation of dosing strategies to achieve targeted tacrolimus exposure after adult kidney transplantationStørset, E., Holford, N., Hennig, S., Bergmann, T. K., Bergan, S., Bremer, S., Åsberg, A., Midtvedt, K. and Staatz, C. E. (2014). Evaluation of dosing strategies to achieve targeted tacrolimus exposure after adult kidney transplantation. Population Approach Group in Europe Conference, Alicante, Spain, June 2014. |
|
2014 Book Chapter Pharmacokinetic, pharmacogenetic and pharmacodynamic monitoring of tacrolimus, mycophenolate and oral corticosteroids in adult kidney transplantationBarraclough, K. A., Staatz, C. E. and Isbel, N. M. (2014). Pharmacokinetic, pharmacogenetic and pharmacodynamic monitoring of tacrolimus, mycophenolate and oral corticosteroids in adult kidney transplantation. The Complex Evolution of Kidney Transplantation: Pre-transplant Donor and Recipient Assessment, Transplant Surgery, Immunosuppression, High Risk Transplants and Management of Post Transplant Complications. (pp. 185-261) edited by Wai Hon Lim. New York, NY, USA: Nova Science Publisher. |
|
2014 Conference Publication Comparing utilisation of mycophenolate, tacrolimus, cyclosporin, sirolimus and everolimus in Australia and Northern EuropeStaatz, C. E., Gardiner, K. M. and Tett, S. E. (2014). Comparing utilisation of mycophenolate, tacrolimus, cyclosporin, sirolimus and everolimus in Australia and Northern Europe. Joint meeting of ASCEPT and Molecular Pharmacology of G protein-coupled receptors (MGPPCR), Melbourne, Australia, 7-11th December 2014. |
|
2014 Conference Publication Comparing exposure monitoring methods for once daily tobramycin in children with cystic fibrosisStiller, Franziska, Staatz, Christine, Teo, Beverly and Hennig, Stefanie (2014). Comparing exposure monitoring methods for once daily tobramycin in children with cystic fibrosis. Population Approach Group in Australia and New Zealand conference,, Dunedin, New Zealand, February. |
|
2014 Conference Publication Comparing dosage adjustment methods for once daily tobramycin in children with cystic fibrosisHennig, Stefanie, Teo, Beverly, Stiller, Franziska and Staatz, Christine (2014). Comparing dosage adjustment methods for once daily tobramycin in children with cystic fibrosis. PAGANZ 2014: 16th Annual Population Approach Group in Australia and New Zealand Meeting, Dunedin, New Zealand, 29-31 January, 2014. Auckland Central, Auckland, NZ: Population Approach Group of Australia and New Zealand (PAGANZ ). |
|
2014 Conference Publication A survey of intravenous tobramycin monitoring and dosage adjustment practice in cystic fibrosis patients in Australia and the United KingdomStaatz, C. E., Paviour, S. and Hennig, S. (2014). A survey of intravenous tobramycin monitoring and dosage adjustment practice in cystic fibrosis patients in Australia and the United Kingdom. Population Approach Group in Europe conference, Alicante, Spain, June 2014. |
|
2014 Conference Publication Cyclosporine and tacrolimus patients have similar dose adjusted prednisolone exposureBergmann, TB, Isbel, NM, Barraclough, KA, Campbell, SB, McWhinney, BC and Staatz, CE (2014). Cyclosporine and tacrolimus patients have similar dose adjusted prednisolone exposure. Annual meeting of the Danish Society of Pharmacology conference, Odense, Denmark, Janurary. |
|
2013 Journal Article Effects of combinational CYP3A5 6986A>G polymorphism in graft liver and native intestine on the pharmacokinetics of tacrolimus in liver transplant patients: a meta-analysisBuendia, Jefferson A., Bramuglia, Guillermo and Staatz, Christine E. (2013). Effects of combinational CYP3A5 6986A>G polymorphism in graft liver and native intestine on the pharmacokinetics of tacrolimus in liver transplant patients: a meta-analysis. Therapeutic Drug Monitoring, 36 (4), 442-447. doi: 10.1097/FTD.0000000000000032 |
|
2013 Journal Article PharmGKB summary: cyclosporine and tacrolimus pathwaysBarbarino, Julia M., Staatz, Christine E., Venkataramanan, Raman, Klein, Teri E. and Altman, Russ B. (2013). PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenetics and Genomics, 23 (10), 563-585. doi: 10.1097/FPC.0b013e328364db84 |
|
2013 Journal Article Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune diseaseAbd Rahman, Azrin N., Tett, Susan E. and Staatz, Christine E. (2013). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease. Clinical Pharmacokinetics, 52 (5), 303-331. doi: 10.1007/s40262-013-0039-8 |
|
2013 Journal Article A differential impact of mycophenolic acid, prednisolone, and tacrolimus exposure on scd30 levels in adult kidney transplant recipientsBarraclough, Katherine A., Staatz, Christine E., Johnson, David W., Gillis, David, Lee, Katie J., McWhinney, Brett C., Ungerer, Jacobus P. J., Campbell, Scott B. and Isbel, Nicole M. (2013). A differential impact of mycophenolic acid, prednisolone, and tacrolimus exposure on scd30 levels in adult kidney transplant recipients. Therapeutic Drug Monitoring, 35 (2), 240-245. doi: 10.1097/FTD.0b013e31828286dd |
|
2013 Journal Article Population pharmacokinetics of tobramycin in patients with and without cystic fibrosisHennig, Stefanie, Standing, Joseph F., Staatz, Christine E. and Thomson, Alison H. (2013). Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis. Clinical Pharmacokinetics, 52 (4), 289-301. doi: 10.1007/s40262-013-0036-y |
|
2013 Conference Publication Usage and monitoring of intravenous tobramycin in cystic fibrosis in Australia and the United KingdomPaviour, Sophie, Hennig, Stefanie and Staatz, Christine (2013). Usage and monitoring of intravenous tobramycin in cystic fibrosis in Australia and the United Kingdom. 39th SHPA National Conference, Cairns, Australia, 19-22 September 2013. |
|
2013 Conference Publication Population pharmacokinetics of tacrolimus in adult kidney transplant recipientsStaatz, C. E., Bergmann, T. K., Barraclough, K. A., Isbel, N. M. and Hennig, S. (2013). Population pharmacokinetics of tacrolimus in adult kidney transplant recipients. Population Approach Group in Europe conference, Glasgow, Scotland, June 2013. |
|
2013 Conference Publication A review of population pharmacokinetic and pharmacodynamic studies of mycophenolate in Autoimmune Disease patientsAbu Rahman, A. N., Tett, S. E. and Staatz, C. E. (2013). A review of population pharmacokinetic and pharmacodynamic studies of mycophenolate in Autoimmune Disease patients. Population Approach Group in Australia and New Zealand conference, Brisbane, QLD, Australia, February 2013. |
|
2013 Conference Publication Effect of the CYP3A5 6986A > G Polymorphism on Tacrolimus Pharmacokinetics in Liver Transplant Recipients: A Meta-analysisBuendia, J. A., Bramuglia, G. and Staatz, C. E. (2013). Effect of the CYP3A5 6986A > G Polymorphism on Tacrolimus Pharmacokinetics in Liver Transplant Recipients: A Meta-analysis. 13th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Salt Lake City Ut, 22-26 September 2013. Philadelphia, PA United States: Lippincott Williams and Wilkins. doi: 10.1097/FTD.0b013e3182a8ef2b |
|
2013 Conference Publication Identification of continuous covariate relationshipsStørset, Elisabet, Staatz, Christine, Hennig, Stefanie, Bergmann, Troels K. and Holford, Nick (2013). Identification of continuous covariate relationships. 15th Annual Population Approach Group Australia and New Zealand Meeting (PAGANZ 2013), Brisbane, QLD, Australia, 13-15 February 2013. |
|
2013 Conference Publication A population pharmacokinetic model of tacrolimus in adult kidney transplant recipients.Bergmann, T. K., Hennig, S., Barraclough, K. A., Isbel, N. M. and Staatz, C. E. (2013). A population pharmacokinetic model of tacrolimus in adult kidney transplant recipients.. Annual meeting of the Danish Society of Pharmacology conference, Odense, Denmark, January 2013. |
|
2013 Journal Article Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting Dose.Bergman, Troels K., Hennig, Stefanie, Barraclough, Katherine A., Isbe,l Nicole M. and Staatz, Christine E. (2013). Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting Dose.. Therapeutic Drug Monitoring, 36 (1), 62-70. doi: 10.1097/FTD.0b013e31829f1ab8 |
